If your email program has trouble displaying this email, view as a webpage.

Update on Hintermann Series H3 Total Ankle Replacement Post-Approval Study Data: FDA Safety Communication

The FDA is providing an update on post-approval study data for the Hintermann Series H3 Total Ankle Replacement (TAR) system, manufactured by DT MedTech LLC.

The FDA is committed to communicating with health care providers and the public, when needed, to ensure the health and safety of patients in support of our mission to protect and promote public health.

Questions?

If you have questions, contact CDRH’s Division of Industry and Consumer Education (DICE).